Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ge healthcare buchler gmbh & co. kg, nemecko - jodid sodný (131j) - 88 - radiopharmaca

Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ge healthcare buchler gmbh & co. kg, nemecko - terapeutické rádiofarmaká - 88 - radiopharmaca

Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi s.r.o., Česká republika - rozpúšťadlá a riedidlá, vrátane irigačných roztokov - 76 - infundibilia

Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

as kalceks, lotyšsko - nátriumoxybát - 06 - psychostimulantia (nootropne lieČ., analeptika)

Eiropas Savienība - slovāku - EMA (European Medicines Agency)

swedish orphan biovitrum ab - kolagenázy clostridium histolyticum - dupuytrenová kontraktúra - iné lieky na poruchy muskuloskeletálneho systému - , the treatment of dupuytren’s contracture in adult patients with a palpable cord. , liečbu dospelých mužov s peyronieho chorobu s zreteľný doska a zakrivenie deformity najmenej 30 stupňov na začiatku terapie.

Slovākija - slovāku - ŠÚKL (Štátny ústav pre kontrolu liečiv)

fresenius kabi s.r.o., Česká republika - elektrolyty - 76 - infundibilia

Eiropas Savienība - slovāku - EMA (European Medicines Agency)

krka, d.d., novo mesto  - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - imunosupresíva - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikovaný na liečbu dospelých predtým neliečených pacientov s myelómom je mladších, ktorí nie sú spôsobilí na transplantáciu. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Eiropas Savienība - slovāku - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakteriálne pre systémové použitie, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. je treba vziať do úvahy oficiálne usmernenie o vhodnom používaní antibakteriálne agentov.